/
Disclosures The presenter has no financial interest in any products or services mentioned Disclosures The presenter has no financial interest in any products or services mentioned

Disclosures The presenter has no financial interest in any products or services mentioned - PowerPoint Presentation

trish-goza
trish-goza . @trish-goza
Follow
351 views
Uploaded On 2018-12-08

Disclosures The presenter has no financial interest in any products or services mentioned - PPT Presentation

AOA Focus March 2018 AOA Focus March 2018 Opioid prescriptions per year per 100 persons History of Drug Control International International Opium Convention of 1912 Convention for Limiting the Manufacture and Regulating the Distribution of Narcotic Drugs of 1931 ID: 738898

drug schedule 325 drugs schedule drug drugs 325 opioid prescription morphine substances codeine practitioner opium controlled 300 acetaminophen pain

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Disclosures The presenter has no financi..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Disclosures

The presenter has no financial interest in any products or services mentioned in the lecture.Slide2

AOA Focus, March 2018Slide3

AOA Focus, March 2018Slide4
Slide5
Slide6

Opioid prescriptions per year

per 100 personsSlide7

History of Drug Control

International

International

Opium Convention of 1912

Convention

for Limiting the Manufacture and Regulating the Distribution of Narcotic Drugs of 1931

Single

Convention on Narcotic Drugs of 1961Slide8

History of Drug Control

United States

Pure

Food and Drug Act of 1906

Federal

Food, Drug, and Cosmetic Act of 1938

Kefauver

Harris Amendment of 1962

Controlled

Substances Act of 1970Slide9

History of Drug Control

Oklahoma

Oklahoma

Oral Medication & Controlled Substance Act of 1994

10/6/2014

changes to schedule II controlled substances

Prescription

Monitoring Program went into effect November 1, 2015Slide10
Slide11
Slide12
Slide13
Slide14

JAMA April 2016Slide15
Slide16

From

NBCNews.com

...

 Opioid Crisis Batters Georgia as Suspicious Percocet Kills Two 

http://www.nbcnews.com/storyline/americas-heroin-epidemic/opioid-crisis-batters-georgia-suspicious-percocet-kills-two-n768951?cid=eml_onsiteSlide17

Definitions

Narcotic

a

drug or other substance affecting mood or behavior and sold for nonmedical purposes, especially an illegal one.

a

drug that relieves pain and induces drowsiness, stupor, or insensibility.

The

term "narcotic" is believed to have been coined by the Greek physician Galen to refer to agents that numb or deaden, causing loss of feeling or paralysis. It is based on the Greek word να

ρκωσις

(narcosis), the term used by Hippocrates for the process of numbing or the numbed state.

(Wikipedia)Slide18

Definitions

Opioid

an

opium-like compound that binds to one or more of the three opioid receptors of the body.

Opiate

a

drug with morphine-like effects, derived from opium.Slide19

Drug Schedules Slide20

Schedules I

Schedule

I drugs, substances, or chemicals are defined as drugs with no currently accepted

medical

use and a high potential for abuse

.

Potentially

severe psychological or physical dependence

Heroin

,

LSD, marijuana, ecstasySlide21

Schedule II

Schedule

II drugs, substances, or chemicals are defined as drugs with a high potential for

abuse

Use

potentially leading to severe psychological or physical dependence

.

Vicodin,

cocaine, methamphetamine, methadone,

oxycodone

(OxyContin),

Adderall

, and RitalinSlide22

Schedule III

Substances

, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence.

Tylenol

with

codeine,

ketamine, anabolic steroids, testosteroneSlide23

Schedule IV

Schedule

IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence.

Xanax

, Soma

, Valium

, Ativan,

Talwin

, Ambien, TramadolSlide24

Schedule V

Schedule

V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes.

Cough

preparations with less than 200 milligrams of codeine or per 100 milliliters (Robitussin AC),

Lomotil

,

Motofen

, Lyrica,

ParepectolinSlide25

Drugs

Opium has three main components:

Morphine

Codeine

ThebaineSlide26

Morphine

In

1803,

morphine

, the principal ingredient in opium, was extracted from opium resin

.

Morphine

is ten times more powerful than processed opium, quantity for quantity.

Morphine remains

the standard against which new pain relievers are measured.

Heroin

is synthesized from Morphine.Slide27

Codeine

Codeine

has less pain-killing ability than morphine and is usually taken

orally

As

a cough suppressant, it is found in a number of liquid

preparations

Hydrocodone

is a semi-synthetic opioid synthesized from codeineSlide28

Thebaine

Oxycodone

is synthesized from

thebaine

Like

morphine,

oxycodone

is used for pain

relief, and is taken orally

When

abused,

oxycodone

tablets are crushed and snorted, or dissolved in water and

injectedSlide29

Mechanism of Action

NSAIDs

work on the peripheral nervous system

Opioids

work on the central nervous systemSlide30

Dosage

Zohydro

ER (

hydrocodone

) 10, 12, 20, 30, 40, 50

Roxicet

,

Endocet

, Percocet (

oxycodone/acetaminophen

) 2.5/325, 5/325, 7.5/325, 10/325

Vicodin

,

Lorcet

, Lortab, Norco,

Xodol

,

Hycet

(

hydrocodone/acetaminophen

) 2.5/325, 5/300, 5/325, 7.5/300, 7.5/325, 10/300, 10/325

Ibudone

,

Reprexain

,

Vicoprofen

(

hydrocodone/ibuprofen

) 2.5/200,5/200,7.5/200,10/200

Tylenol

with Codeine (

acetaminophen/codeine

) 300/15, 300/30, 300/60

Ultram

(

tramadol

) 50mgSlide31

Prescribing

Schedule II

Hydrocodone/

acetominophen

5/325

#12

1 tablet PO q4-6

hrs

Schedule III

Tylenol #3 (

acetominophen

/codeine) 300/30

#12

1 tablet PO q4-6

hrs

Consult pharmacist for pediatric dosingSlide32

Contraindications

Use

of other acetaminophen-containing drugs

Acetaminophen

associated with acute liver failure include cases of liver transplant and death; most liver injury associated with acetaminophen doses >4000 mg per day and >1 acetaminophen-containing

product

Concurrent benzodiazepine useSlide33

Side Effects

Serious

Respiratory

depression

Hepatotoxicity

Common

Constipation

Drowsiness

Nausea

and vomitingSlide34

Relative Strength

(weakest to strongest)

Tramadol

Codeine

Morphine

Hydrocodone

OxcycodoneSlide35

Pricing

Zyhydro

ER

($7.78 brand only

)

Percocet

5/325 ($11.95 brand,

$0.49

generic

)

Lortab

5/325 ($0.31 brand,

$0.23 generic

)

Vicoprofen

7.5/200 ($15.60 brand,

$0.24 generic

)

Tylenol

III ($1.44 brand,

$0.36 generic

)

Ultram

($2.77 brand,

$0.07 generic

)Slide36

Definitions

Addiction

: a medical condition characterized by compulsive engagement in rewarding stimuli despite adverse consequences

Dependence

: an adaptive state associated with a withdrawal syndrome upon cessation of repeated exposure to a stimulus (e.g., drug intake)

Tolerance

: the diminishing effect of a drug resulting from repeated administration at a given doseSlide37

DEA Rules for

Prescribing Controlled Substances

All

controlled

substances

Schedule II

Schedules

III-VSlide38

All Controlled Substances

Must have a DEA numberSlide39

All Controlled Substances

A

prescription

must

be dated on the date when

issued

Must

include the patient’s full name and address, and the practitioner’s full name, address, and DEA registration

number

Must

be manually signed by the practitioner on the date when

issuedSlide40

Schedule II

No

refills

May

transmit

facsimile

.

However, the

original

prescription

must be presented to the pharmacist

prior

to the actual

dispensing.

Exceptions:

Long

Term Care Facilities (

LTCF)

Hospice Care Program.

The practitioner or agent will note on the prescription that it is for a hospice patient.

Slide41

Schedule II

In an emergency, a practitioner may call-in a

prescription

The

quantity prescribed and dispensed is limited to the amount adequate to treat the patient during the emergency period.

The

prescribing practitioner must provide a written and signed prescription to the pharmacist within

seven days

. Further, the pharmacist must notify DEA if the prescription is not received.Slide42

Schedules III-V

Prescriptions may

be transmitted by

facsimile

from the practitioner or an employee or agent of the individual practitioner to the dispensing pharmacy. The facsimile is considered to be equivalent to an original prescription.

A

pharmacist may dispense

an

oral prescription

made by an individual

practitioner. It must contain all

information required for a valid prescription, except for the signature of the practitioner.Slide43

www.dea.govSlide44
Slide45
Slide46

CDC Guidelines Summary

Non-opioid

therapy is preferred for chronic pain

outside of active cancer, palliative, and end-of-life care. Opioids should only be used when their benefits are expected to outweigh their substantial risks.

When

opioids are used, the

lowest possible effective dosage should be prescribed

to reduce risks of opioid use disorder and overdose. Clinicians should start low and go slow.

Providers

should always exercise caution when prescribing opioids and

monitor all patients closely

. Clinicians should minimize risk to patients—whether checking the state prescription drug monitoring program, or having an ‘off-ramp’ plan to taper. Slide47

Drug Seeking Behavior

Patient-described

pain level not matching what’s observed or reporting a 10-out-of-10 pain

threshold

Requesting

medication by

name

Requesting

a

specific dosage

Reporting

lost or stolen

medications

Requesting

a

refill

.

AOA Focus, March 2018Slide48

Patient Resources

The

Substance Abuse and Mental Health Services Administration (SAMHSA) has a National Helpline, 

1-800-662-HELP (4357)

, for those with a possible opioid use disorder.  The Helpline is a confidential, free, 24-hour-a-day, 365-day-a-year, information service, in English and Spanish, for individuals and family members facing mental and/or substance use disorders.

To

find an authorized Opioid Treatment Program dispensing methadone or buprenorphine to treat opioid dependency in your state visit:

http://dpt2.samhsa.gov/treatment/directory.aspx

To find an authorized DEA Registered Practitioner to treat opioid dependency with buprenorphine in your state visit:

https://www.samhsa.gov/medication-assisted-treatment/physician-program-data/treatment-physician-locator